Trendlines Group Ltd. holds a minority stake in IBI Ag, an affiliate that has completed a $10 million Series A funding round. IBI Ag develops antibody-based bio-insecticides for crop protection, with the round led by Corteva and joined by several other investors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trendlines Group Ltd. published the original content used to generate this news brief on November 11, 2025, and is solely responsible for the information contained therein.